FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366334580> ?p ?o ?g. }

• W4366334580 abstract "Abstract Background Immune checkpoint inhibitors (ICI) have revolutionized the management of cancer. They can induce immune-related adverse events (irAE) leading to intensive care unit (ICU) admission. We aimed to describe irAEs for ICU admissions in solid cancer patients treated with ICIs. Methods This prospective multicenter study was conducted in France and Belgium. Adult patients with solid tumor and treated with systemic ICIs within the last 6 months, requiring non-programmed ICU admission were included. Patients admitted for microbiologically documented sepsis were excluded. Imputability of irAEs in ICU admissions was described according to the WHO-UMC classification system at ICU admission and at ICU discharge. The use of immunosuppressant treatment was reported. Results 115 patients were eligible. Solid tumor was mainly lung cancer (n = 76, 66%) and melanoma (n = 18, 16%). They were mainly treated with an anti-PD-(L)1 alone (n = 110, 96%). Main ICU admission reasons were acute respiratory failure (n = 66, 57%), colitis (n = 14, 13%), and cardiovascular disease (n = 13, 11%). ICU admission was considered “likely” associated with irAE for 48% (n = 55) of patients. Factors independently associated with irAE were a good ECOG performance status (PS) (ECOG-PS of 0 or 1 vs. ECOG-PS of 2–3, odds ratio [OR] = 6.34, 95% confidence interval [95% CI] 2.13–18.90, and OR = 3.66, 95% CI 1.33–10.03, respectively), and a history of irAE (OR = 3.28, 95% CI 1.19–9.01). Steroids were prescribed for 41/55 (75%) patients with ICU admission “likely” related to irAE. Three patients were subsequently treated with immunosuppressants. Conclusion IrAEs accounted for half of ICU admissions in cancer patients receiving ICIs. They could be treated with steroids. Identifying the imputability of irAEs in ICU admissions remains a challenge." @default.
• W4366334580 created "2023-04-20" @default.
• W4366334580 creator A5002584782 @default.
• W4366334580 creator A5013413007 @default.
• W4366334580 creator A5014038206 @default.
• W4366334580 creator A5015902606 @default.
• W4366334580 creator A5022975840 @default.
• W4366334580 creator A5028953047 @default.
• W4366334580 creator A5051739641 @default.
• W4366334580 creator A5062179226 @default.
• W4366334580 creator A5062366344 @default.
• W4366334580 creator A5062392021 @default.
• W4366334580 creator A5062603720 @default.
• W4366334580 creator A5065098475 @default.
• W4366334580 creator A5068262198 @default.
• W4366334580 creator A5073194089 @default.
• W4366334580 creator A5076578951 @default.
• W4366334580 creator A5083558953 @default.
• W4366334580 creator A5086678812 @default.
• W4366334580 date "2023-04-18" @default.
• W4366334580 modified "2023-10-08" @default.
• W4366334580 title "ICU admission for solid cancer patients treated with immune checkpoint inhibitors" @default.
• W4366334580 cites W2547133566 @default.
• W4366334580 cites W2606778219 @default.
• W4366334580 cites W2786816161 @default.
• W4366334580 cites W2791483720 @default.
• W4366334580 cites W2945262187 @default.
• W4366334580 cites W2945590213 @default.
• W4366334580 cites W2955729565 @default.
• W4366334580 cites W2989217594 @default.
• W4366334580 cites W3093029731 @default.
• W4366334580 cites W3095154565 @default.
• W4366334580 cites W3108129662 @default.
• W4366334580 cites W3120362667 @default.
• W4366334580 cites W3172447649 @default.
• W4366334580 cites W4281714393 @default.
• W4366334580 doi "https://doi.org/10.1186/s13613-023-01122-z" @default.
• W4366334580 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37072645" @default.
• W4366334580 hasPublicationYear "2023" @default.
• W4366334580 type Work @default.
• W4366334580 citedByCount "3" @default.
• W4366334580 countsByYear W43663345802023 @default.
• W4366334580 crossrefType "journal-article" @default.
• W4366334580 hasAuthorship W4366334580A5002584782 @default.
• W4366334580 hasAuthorship W4366334580A5013413007 @default.
• W4366334580 hasAuthorship W4366334580A5014038206 @default.
• W4366334580 hasAuthorship W4366334580A5015902606 @default.
• W4366334580 hasAuthorship W4366334580A5022975840 @default.
• W4366334580 hasAuthorship W4366334580A5028953047 @default.
• W4366334580 hasAuthorship W4366334580A5051739641 @default.
• W4366334580 hasAuthorship W4366334580A5062179226 @default.
• W4366334580 hasAuthorship W4366334580A5062366344 @default.
• W4366334580 hasAuthorship W4366334580A5062392021 @default.
• W4366334580 hasAuthorship W4366334580A5062603720 @default.
• W4366334580 hasAuthorship W4366334580A5065098475 @default.
• W4366334580 hasAuthorship W4366334580A5068262198 @default.
• W4366334580 hasAuthorship W4366334580A5073194089 @default.
• W4366334580 hasAuthorship W4366334580A5076578951 @default.
• W4366334580 hasAuthorship W4366334580A5083558953 @default.
• W4366334580 hasAuthorship W4366334580A5086678812 @default.
• W4366334580 hasBestOaLocation W43663345801 @default.
• W4366334580 hasConcept C121608353 @default.
• W4366334580 hasConcept C126322002 @default.
• W4366334580 hasConcept C156957248 @default.
• W4366334580 hasConcept C197934379 @default.
• W4366334580 hasConcept C2776256026 @default.
• W4366334580 hasConcept C2776376669 @default.
• W4366334580 hasConcept C2778384902 @default.
• W4366334580 hasConcept C2779526319 @default.
• W4366334580 hasConcept C42219234 @default.
• W4366334580 hasConcept C44249647 @default.
• W4366334580 hasConcept C71924100 @default.
• W4366334580 hasConceptScore W4366334580C121608353 @default.
• W4366334580 hasConceptScore W4366334580C126322002 @default.
• W4366334580 hasConceptScore W4366334580C156957248 @default.
• W4366334580 hasConceptScore W4366334580C197934379 @default.
• W4366334580 hasConceptScore W4366334580C2776256026 @default.
• W4366334580 hasConceptScore W4366334580C2776376669 @default.
• W4366334580 hasConceptScore W4366334580C2778384902 @default.
• W4366334580 hasConceptScore W4366334580C2779526319 @default.
• W4366334580 hasConceptScore W4366334580C42219234 @default.
• W4366334580 hasConceptScore W4366334580C44249647 @default.
• W4366334580 hasConceptScore W4366334580C71924100 @default.
• W4366334580 hasFunder F4320307779 @default.
• W4366334580 hasIssue "1" @default.
• W4366334580 hasLocation W43663345801 @default.
• W4366334580 hasLocation W43663345802 @default.
• W4366334580 hasLocation W43663345803 @default.
• W4366334580 hasOpenAccess W4366334580 @default.
• W4366334580 hasPrimaryLocation W43663345801 @default.
• W4366334580 hasRelatedWork W128001744 @default.
• W4366334580 hasRelatedWork W1943617196 @default.
• W4366334580 hasRelatedWork W2014790323 @default.
• W4366334580 hasRelatedWork W2034320513 @default.
• W4366334580 hasRelatedWork W2048615777 @default.
• W4366334580 hasRelatedWork W2058883536 @default.
• W4366334580 hasRelatedWork W2076929529 @default.
• W4366334580 hasRelatedWork W2329364306 @default.
• W4366334580 hasRelatedWork W2398800724 @default.
• W4366334580 hasRelatedWork W96175412 @default.

• next